ChemicalBook >
제품 카탈로그 >(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-(4-fluorophenylaMino)(4-hydroxyphenyl)Methyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-(4-fluorophenylaMino)(4-hydroxyphenyl)Methyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-(4-fluorophenylaMino)(4-hydroxyphenyl)Methyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one 속성
- 끓는 점
- 799.5±60.0 °C(Predicted)
- 밀도
- 1.362±0.06 g/cm3(Predicted)
- 산도 계수 (pKa)
- 9.93±0.26(Predicted)
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
그림문자(GHS): |
|
신호 어: |
Warning |
유해·위험 문구: |
암호 |
유해·위험 문구 |
위험 등급 |
범주 |
신호 어 |
그림 문자 |
P- 코드 |
H302 |
삼키면 유해함 |
급성 독성 물질 - 경구 |
구분 4 |
경고 |
|
P264, P270, P301+P312, P330, P501 |
H315 |
피부에 자극을 일으킴 |
피부부식성 또는 자극성물질 |
구분 2 |
경고 |
|
P264, P280, P302+P352, P321,P332+P313, P362 |
H319 |
눈에 심한 자극을 일으킴 |
심한 눈 손상 또는 자극성 물질 |
구분 2A |
경고 |
|
P264, P280, P305+P351+P338,P337+P313P |
H335 |
호흡 자극성을 일으킬 수 있음 |
특정 표적장기 독성 - 1회 노출;호흡기계 자극 |
구분 3 |
경고 |
|
|
|
예방조치문구: |
P261 |
분진·흄·가스·미스트·증기·...·스프레이의 흡입을 피하시오. |
P305+P351+P338 |
눈에 묻으면 몇 분간 물로 조심해서 씻으시오. 가능하면 콘택트렌즈를 제거하시오. 계속 씻으시오. |
|
(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-(4-fluorophenylaMino)(4-hydroxyphenyl)Methyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one C화학적 특성, 용도, 생산
용도
An impurity of Ezetimibe (E975005), an antihyperlipoproteinemic and cholesterol absorption inhibitor.
(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-(4-fluorophenylaMino)(4-hydroxyphenyl)Methyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one 준비 용품 및 원자재
원자재
준비 용품
(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-(4-fluorophenylaMino)(4-hydroxyphenyl)Methyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one 공급 업체
글로벌( 39)공급 업체
(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-(4-fluorophenylaMino)(4-hydroxyphenyl)Methyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one 관련 검색:
EzetiMibe (3R,4R,3'S)-IsoMer
3-[5-(1,5-Dioxo-5-(p-fluophenylpentyl]-4R-phenyl-2-oxazolidinone
(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
Ezetimibe Diacetate
EZETIMIBE-D4
(R)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
4-[[(4-Fluorophenyl)imino]methyl]-phenol
(4S)-3-[(5R)-5-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL]-4-PHENYL-1,3-OXAZOLIDIN-2-ONE
Methyl (3R,4S)-1-(4-fluorophenyl)-2-oxo-4-[4-(phenylmethoxy)phenyl]-3-azetidinepropanoate
(3R,4S)-1-(4-Fluorophenyl)-2-oxo-4-[4-(benzyloxy)phenyl]-3-azetidinepropanoic acid
(3R,4S)-1-(4-chlorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one
(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone
(3S,4S)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one
EzetiMibe IMpurity 1
(αR,δS)-4-Fluoro-N-(4-fluorophenyl)-δ-hydroxy-α-[(4-hydroxyphenyl)Methyl]benzenepentanaMide
(3’R)-Ezetimibe
EzetiMibe LactaM Cleaved Alcohol
EZETIMIBE PHENOXY GLUCURONIDE